Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 13 Analysts

Rhythm Pharmaceuticals (NASDAQ:RYTM) has been analyzed by 13 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Analyst Expectations For Sarepta Therapeutics's Future

14 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga

I love the ingenious design of this women’s health brand logo

Design Bridge and Partners create a pioneering brand for the future.

Creative Bloq

From analysis to the latest developments in health,
read the most diverse news in one place.

Democrats can still lower drug prices

High medication costs are a common enemy for Democrats, Republicans and patients. There's still time to fight

Salon

Lilly Sues US Agency For Blocking Proposed Drug Rebate Plan

Eli Lilly is taking the HRSA to court for allegedly blocking the pharma's discount plan.

International Business Times

FDA Implements New Rules For Drug Advertisements

New FDA guidelines enhance transparency in TV drug ads by requiring clearer risk information and neutral presentation of side effects.

Top News

New FDA rules for TV drug ads: Simpler language and no distractions

New rules require drugmakers to be clearer about explaining the risks and side effects of prescription drugs

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

23andMe is laying off 40% of its workforce right before the holiday season

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile data breach, several rounds of previous layoffs and piling losses that plunged the company’s stock over recent years

The Independent UK

AstraZeneca’s numbers are good but trouble in China could drag it down

Profits beat forecasts but a 17% fall in share price since executives were detained by Beijing may be hard to shake

The Guardian - UK

23andMe cuts 40% of its workforce and discontinues therapeutics division

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs

The Independent UK

AstraZeneca says it takes China investigation ‘very seriously’

UK’s biggest pharmaceutical company ‘committed to China’ as it raises 2024 profit forecast and announces $3.5bn US investment

The Guardian - UK

All that You Really want to Be familiar with Arimidex

Arimidex (Anastrozole) is a major area of strength for an inhibitor reliably used to direct estrogen levels in both sensible and lifting loads settings. At first expected to oversee chest most harmful developments in postmenopausal women, Arimidex ...

USA Today Sports Media Group

Obesity Drug Maker Novo Nordisk Posts Strong Profit

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints.

International Business Times

AstraZeneca shares tumble after reports China unit is linked to insurance fraud

Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

StockNews.com

3 Biotechnology Stocks With Promising Pipelines

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming. Therefore, it could be wise to invest in solid biotech stocks Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD) for substantial returns. Read more.

The Independent UK

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

Demand for the popular weight loss and diabetes drugs has spiked dramatically in recent years

Kiplinger

Why Pfizer Stock Is Lower After a Beat-and-Raise Quarter

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

Get all your
news in one place.

100’s of premium titles.
One news app.

Latin Times

Cheap Mexican Drugs Forcing Canadian Cartels to Export Meth to Other Countries

Canadian manufacturers of methamphetamine are being pushed to begin selling their product in foreign markets after being unable to compete with cheaper product from Mexico circulating in their home market.

The Guardian - AU

More than half of WA pharmacies choosing not to stock vapes, survey shows

Exclusive: Uncertainty over regulations and discomfort over stocking a product not evaluated by drugs regulator among reasons given

The Guardian - UK

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly

Latin Times

Missouri Seeks to Block Access to Abortion Pill Because It's Stopping Teens from Getting Pregnant

Fewer teenage pregnancies means a population loss for the states, as well as "diminishment of political representation and loss of federal funds."

StockNews.com

3 Pharma Stocks to Watch as Gene Therapy Gains Momentum

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and improve treatment options. Given this favorable trend, it could be wise to watch strong pharma stocks such as Vertex Pharmaceuticals (VRTX), Wave Life Sciences (WVE), and Poseida Therapeutics (PSTX). Read more.

The Independent UK

US series with ‘most agonising cliffhanger’ in years is finally returning

Fans have been waiting more than two years for show to return

Radio France Internationale

Sanofi confirms €16 billion sale of painkiller Doliprane to US investors

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.